JS, D., CP, W., J, H., JE, M., & EH, S. (2024). Clinicopathologic features of pityriasis rosea-like drug eruption secondary to imatinib: A case report and review of the literature. Journal of cutaneous pathology, 51(11), 860. https://doi.org/10.1111/cup.14692
Chicago Style (17th ed.) CitationJS, Durgin, Whittington CP, Harrell J, Mervak JE, and Smith EH. "Clinicopathologic Features of Pityriasis Rosea-like Drug Eruption Secondary to Imatinib: A Case Report and Review of the Literature." Journal of Cutaneous Pathology 51, no. 11 (2024): 860. https://doi.org/10.1111/cup.14692.
MLA (9th ed.) CitationJS, Durgin, et al. "Clinicopathologic Features of Pityriasis Rosea-like Drug Eruption Secondary to Imatinib: A Case Report and Review of the Literature." Journal of Cutaneous Pathology, vol. 51, no. 11, 2024, p. 860, https://doi.org/10.1111/cup.14692.